Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Malpas, Charles (Chief Investigator (CI))
  • Velakoulis, Dennis (Chief Investigator (CI))
  • Brodtmann, Amy (Chief Investigator (CI))
  • Piguet, Olivier (Chief Investigator (CI))
  • Kalincik, Tomas (Chief Investigator (CI))
  • Walterfang, Mark (Chief Investigator (CI))
  • Ahmed, Rebekak (Chief Investigator (CI))
  • Bush, Ashley Ian (Chief Investigator (CI))
  • Darby, David (Chief Investigator (CI))

Project: Research

Short titleSodium selanate in patients with bvFTD
StatusActive
Effective start/end date1/04/1931/03/24

Funding

  • The Department of Health (Comm): AUD1,604,184.40